Novartis Ag Adr Stock Price Prediction

NVS Stock  USD 95.88  0.61  0.64%   
At this time, the relative strength index (RSI) of Novartis' share price is approaching 49. This indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Novartis, making its price go up or down.

Oversold Vs Overbought

49

 
Oversold
 
Overbought
Novartis AG ADR stock price prediction is an act of determining the future value of Novartis shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Novartis' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Novartis and does not consider all of the tangible or intangible factors available from Novartis' fundamental data. We analyze noise-free headlines and recent hype associated with Novartis AG ADR, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Novartis' stock price prediction:
Quarterly Earnings Growth
4.987
EPS Estimate Next Quarter
1.8
EPS Estimate Current Year
7.14
EPS Estimate Next Year
7.88
Wall Street Target Price
113.01
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Novartis based on different types of headlines from major news networks to social media. The Novartis stock price prediction module provides an analysis of price elasticity to changes in media outlook on Novartis over a specific investment horizon. Using Novartis hype-based prediction, you can estimate the value of Novartis AG ADR from the perspective of Novartis response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Novartis using Novartis' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Novartis using crowd psychology based on the activity and movement of Novartis' stock price.

Novartis Short Interest

A significant increase or decrease in Novartis' short interest from the previous month could be a good indicator of investor sentiment towards Novartis. Short interest can provide insight into the potential direction of Novartis stock and how bullish or bearish investors feel about the market overall. An investor who is long Novartis may also wish to track short interest. As short interest increases, investors should be becoming more worried about Novartis and may potentially protect profits, hedge Novartis with its derivative instruments, or be ready for some potential downside.
200 Day MA
100.205
Short Percent
0.0026
Short Ratio
2.77
Shares Short Prior Month
3.9 M
50 Day MA
102.1594

Novartis AG ADR Hype to Price Pattern

Investor biases related to Novartis' public news can be used to forecast risks associated with an investment in Novartis. The trend in average sentiment can be used to explain how an investor holding Novartis can time the market purely based on public headlines and social activities around Novartis AG ADR. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Novartis' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Novartis.

Novartis Implied Volatility

    
  13.72  
Novartis' implied volatility exposes the market's sentiment of Novartis AG ADR stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Novartis' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Novartis stock will not fluctuate a lot when Novartis' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Novartis. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Novartis to buy its stock at a price that has no basis in reality. In that case, they are not buying Novartis because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Novartis after-hype prediction price

    
  USD 95.86  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.

Prediction based on Rule 16 of the current Novartis contract

Based on the Rule 16, the options market is currently suggesting that Novartis AG ADR will have an average daily up or down price movement of about 0.86% per day over the life of the 2024-04-19 option contract. With Novartis trading at USD 95.88, that is roughly USD 0.82 . If you think that the market is fully incorporating Novartis' daily price movement you should consider acquiring Novartis AG ADR options at the current volatility level of 13.72%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Check out Novartis Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Novartis' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
86.29105.31106.39
Details
Naive
Forecast
LowNextHigh
92.8193.8894.96
Details
12 Analysts
Consensus
LowTargetHigh
102.60112.75125.15
Details
Earnings
Estimates (0)
LowProjected EPSHigh
1.681.811.89
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Novartis. Your research has to be compared to or analyzed against Novartis' peers to derive any actionable benefits. When done correctly, Novartis' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Novartis AG ADR.

Novartis After-Hype Price Prediction Density Analysis

As far as predicting the price of Novartis at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Novartis or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Novartis, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Novartis Estimiated After-Hype Price Volatility

In the context of predicting Novartis' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Novartis' historical news coverage. Novartis' after-hype downside and upside margins for the prediction period are 94.78 and 96.94, respectively. We have considered Novartis' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
95.88
95.86
After-hype Price
96.94
Upside
Novartis is very steady at this time. Analysis and calculation of next after-hype price of Novartis AG ADR is based on 3 months time horizon.

Novartis Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Novartis is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Novartis backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Novartis, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.02 
1.08
  0.02 
  0.03 
12 Events / Month
6 Events / Month
In about 12 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
95.88
95.86
0.02 
104.85  
Notes

Novartis Hype Timeline

On the 28th of March Novartis AG ADR is traded for 95.88. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of 0.03. Novartis is anticipated to decline in value after the next headline, with the price expected to drop to 95.86. The average volatility of media hype impact on the company price is about 104.85%. The price depreciation on the next news is expected to be -0.02%, whereas the daily expected return is now at -0.02%. The volatility of related hype on Novartis is about 74.15%, with the expected price after the next announcement by competition of 95.91. The book value of the company was now reported as 22.83. The company last dividend was issued on the 7th of March 2024. Novartis AG ADR had 1116:1000 split on the 9th of April 2019. Considering the 90-day investment horizon the next anticipated press release will be in about 12 days.
Check out Novartis Basic Forecasting Models to cross-verify your projections.

Novartis Related Hype Analysis

Having access to credible news sources related to Novartis' direct competition is more important than ever and may enhance your ability to predict Novartis' future price movements. Getting to know how Novartis rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Novartis may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
AAgilent Technologies 3.49 11 per month 1.43 (0.02) 2.27 (2.26) 5.92 
MBIOMustang Bio(0.04)3 per month 0.00 (0.12) 5.30 (8.49) 20.58 
MBRXMoleculin Biotech 5.79 9 per month 0.00 (0.11) 11.19 (11.18) 34.21 
CLVRWClever Leaves Holdings 0.01 2 per month 7.03  0.17  29.03 (12.50) 74.95 
MCRBSeres Therapeutics 0.01 10 per month 0.00 (0.09) 8.70 (8.33) 29.80 
MDGLMadrigal Pharmaceuticals 4.05 8 per month 4.45  0.04  8.89 (7.09) 24.70 
EQEquillium(0.15)10 per month 5.96  0.20  20.33 (10.80) 70.42 
KAKineta Inc(0.02)7 per month 0.00 (0.26) 8.68 (9.84) 72.56 
ME23Andme Holding Co(0.03)11 per month 0.00 (0.11) 10.61 (10.00) 34.64 

Novartis Additional Predictive Modules

Most predictive techniques to examine Novartis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Novartis using various technical indicators. When you analyze Novartis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Novartis Predictive Indicators

The successful prediction of Novartis stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Novartis AG ADR, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Novartis based on analysis of Novartis hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Novartis's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Novartis's related companies.
 2021 2022 2024 (projected)
Price Earnings Ratio7.7326.9213.62
Short Term Coverage Ratios2.292.31.51

Story Coverage note for Novartis

The number of cover stories for Novartis depends on current market conditions and Novartis' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Novartis is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Novartis' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Novartis Short Properties

Novartis' future price predictability will typically decrease when Novartis' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Novartis AG ADR often depends not only on the future outlook of the potential Novartis' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Novartis' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding2.1 B
Cash And Short Term Investments14 B
When determining whether Novartis AG ADR is a strong investment it is important to analyze Novartis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Novartis' future performance. For an informed investment choice regarding Novartis Stock, refer to the following important reports:
Check out Novartis Basic Forecasting Models to cross-verify your projections.
You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Complementary Tools for Novartis Stock analysis

When running Novartis' price analysis, check to measure Novartis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novartis is operating at the current time. Most of Novartis' value examination focuses on studying past and present price action to predict the probability of Novartis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novartis' price. Additionally, you may evaluate how the addition of Novartis to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Is Novartis' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novartis. If investors know Novartis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novartis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
4.987
Dividend Share
3.919
Earnings Share
4.1
Revenue Per Share
22.467
Quarterly Revenue Growth
0.074
The market value of Novartis AG ADR is measured differently than its book value, which is the value of Novartis that is recorded on the company's balance sheet. Investors also form their own opinion of Novartis' value that differs from its market value or its book value, called intrinsic value, which is Novartis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novartis' market value can be influenced by many factors that don't directly affect Novartis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novartis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Novartis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novartis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.